Cerebellum GP LLC bought a new stake in shares of Aramark (NYSE:ARMK) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,975 shares of the company’s stock, valued at approximately $127,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of ARMK. Cullen Frost Bankers Inc. purchased a new position in Aramark during the second quarter valued at $32,000. Squar Milner Financial Services LLC grew its stake in shares of Aramark by 8.4% in the 2nd quarter. Squar Milner Financial Services LLC now owns 3,712 shares of the company’s stock worth $134,000 after buying an additional 288 shares in the last quarter. Machina Capital S.A.S. grew its stake in shares of Aramark by 18.3% in the 2nd quarter. Machina Capital S.A.S. now owns 5,456 shares of the company’s stock worth $197,000 after buying an additional 844 shares in the last quarter. Wetherby Asset Management Inc. purchased a new position in shares of Aramark in the 2nd quarter worth $206,000. Finally, Janney Montgomery Scott LLC purchased a new position in shares of Aramark in the 2nd quarter worth $223,000. 98.52% of the stock is owned by institutional investors.
A number of equities analysts have commented on the stock. Robert W. Baird lifted their price objective on shares of Aramark from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Monday, August 19th. Royal Bank of Canada set a $49.00 price objective on shares of Aramark and gave the stock a “buy” rating in a research note on Monday, August 26th. Barclays lifted their price objective on shares of Aramark from $35.00 to $45.00 and gave the stock an “equal weight” rating in a research note on Thursday, September 19th. They noted that the move was a valuation call. Nomura raised shares of Aramark from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $28.00 to $50.00 in a research note on Monday, August 19th. Finally, TheStreet raised shares of Aramark from a “c+” rating to a “b-” rating in a research note on Friday, July 5th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $45.58.
Aramark (NYSE:ARMK) last released its earnings results on Tuesday, August 6th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.08. The firm had revenue of $4.01 billion during the quarter, compared to analyst estimates of $3.99 billion. Aramark had a net margin of 3.33% and a return on equity of 17.39%. The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business earned $0.48 EPS. As a group, sell-side analysts predict that Aramark will post 2.04 earnings per share for the current fiscal year.
In other news, insider Keith Bethel sold 7,500 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $37.40, for a total value of $280,500.00. Following the completion of the sale, the insider now owns 43,692 shares in the company, valued at approximately $1,634,080.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.30% of the stock is currently owned by company insiders.
Aramark Company Profile
Aramark provides food, facilities management, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients in North America and internationally. It operates in three segments: Food and Support Services United States, Food and Support Services International, and Uniform and Career Apparel.
Want to see what other hedge funds are holding ARMK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aramark (NYSE:ARMK).
Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.